Bemarituzumab (FUT8-KO)

Produktübersicht

• Artikelname: Bemarituzumab (FUT8-KO)
• Artikelnummer: MCE-HY-P99010A
• Hersteller Artikelnummer: HY-P99010A
• Alternativnummer: MCE-HY-P99010A-1MG,MCE-HY-P99010A-10MG,MCE-HY-P99010A-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper

Produktbeschreibung

Bemarituzumab (FUT8-KO) is an anti-FGFR2b monoclonal antibody expressed by CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. Fucose deficiency enhances the ADCC effect of the antibody. Bemarituzumab (FUT8-KO) lacks a core fucose in the polysaccharide portion of the Fc domain of the antibody, and results in a high affinity to human FcgammaRIIIa[1].

Produkteigenschaften

• Molekulargewicht: (143.86 kDa)
• Reinheit: 99.74
• Target-Kategorie: FGFR,Interleukin Related

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies